SK Biopharmaceuticals Co., Ltd. ( 326030.KS) - Key Metrics

326030.KS Revenue per Share metrics
Date Revenue per Share Net Income per Share Operating Cash Flow Free Cash Flow per Share
2025Q4 ? ? ? ?
2025Q3 ₩2,449 ₩947 ₩836 ₩819
2025Q2 ₩2,249 ₩420 -₩43 -₩58
2025Q1 ₩1,844 ₩298 ₩348 ₩347
2024Q4 ₩2,082 ₩2,428 ₩726 ₩718

326030.KS Payout ratio and Price per Earnings ratio
Date Payout ratio PE ratio
2025Q4 ? ?
2025Q3 ? 26.77
2025Q2 ? 54.76
2025Q1 ? 83.42
2024Q4 ? 11.44

326030.KS Free Cash Flow Yield and Dividend Yield
DateFree Cash Flow YieldDividend Yield
2025Q4 ? ?
2025Q3 0.81% ?
2025Q2 -0.06% ?
2025Q1 0.35% ?
2024Q4 0.65% ?

326030.KS

Price: ₩88,100

52 week price:
86900.00
144100.00

Exchange: KSC

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 8.1 trillion

Links: